XAIR
HEALTHCAREBeyond Air Inc
$0.56-0.01 (-2.59%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving XAIR Today?
No stock-specific AI insight has been generated for XAIR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.43$5.84
$0.57
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-4.47
Dividend Yield—
Dividend / Share—
ROE-2.4%
Profit Margin—
Debt / Equity—
Trading
Volume207K
Avg Volume (10D)—
Shares Outstanding10.5M
XAIR News
20 articles- Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026GlobeNewswire Inc.·Apr 20, 2026
- Beyond Air to Participate in the D. Boral Capital Global Conference 2026Yahoo Finance·Apr 15, 2026
- Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)Yahoo Finance·Apr 1, 2026
- Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEOYahoo Finance·Mar 26, 2026
- Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO TrialYahoo Finance·Mar 17, 2026
- Life Sciences Virtual Investor Forum Presentations Now Available for Online ViewingYahoo Finance·Mar 13, 2026
- Beyond Air to Participate in the 38th Annual Roth Conference in MarchYahoo Finance·Mar 11, 2026
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12thYahoo Finance·Mar 10, 2026
- Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.Yahoo Finance·Mar 10, 2026
- Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide TherapiesYahoo Finance·Mar 4, 2026
- How The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed ApprovalYahoo Finance·Feb 25, 2026
- Beyond Air Inc (XAIR) Q3 2026 Earnings Call Highlights: Impressive Revenue Growth and Strategic ...Yahoo Finance·Feb 21, 2026
- Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory InfectionsYahoo Finance·Feb 20, 2026
- Beyond Air, Inc. Q3 2026 Earnings Call SummaryMoby·Feb 13, 2026
- Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate UpdateYahoo Finance·Feb 13, 2026
- Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026Yahoo Finance·Feb 4, 2026
- XTL Update on Recent DevelopmentsYahoo Finance·Jan 29, 2026
- Beyond Air to Participate in Two Upcoming Healthcare Investor ConferencesYahoo Finance·Jan 27, 2026
- Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and WebcastYahoo Finance·Jan 26, 2026
- Top Midday DeclinersYahoo Finance·Jan 14, 2026
All 20 articles loaded
Price Data
Open$0.57
Previous Close$0.58
Day High$0.58
Day Low$0.52
52 Week High$5.84
52 Week Low$0.43
52-Week Range
$0.43$5.84
$0.57
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-4.47
Dividend Yield—
Dividend / Share—
ROE-2.4%
Profit Margin—
Debt / Equity—
Trading
Volume207K
Avg Volume (10D)—
Shares Outstanding10.5M
About Beyond Air Inc
Beyond Air, Inc., a clinical-stage biopharmaceutical and medical device company, develops nitric oxide (NO) generators and delivery systems. The company is headquartered in Garden City, New York.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—